Europe Noninvasive Ventilation Masks Market Trends by 2030

Europe Noninvasive Ventilation Masks Market Size and Forecast (2020 - 2030), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Interfaces (Masks and Accessories), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), Usage (Pediatrics and Adults), Size (Large, Medium, and Small), Material (Silicon, Gel, and Others), Product Type (Single-Use and Reusable), End User (Hospitals, Critical and Acute Care Settings, Ambulatory Surgical Centers, and Others), and Country

  • Report Code : TIPRE00039025
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 180
Buy Now

The Europe noninvasive ventilation masks market size is projected to reach US$ 1,076.68 million by 2030 from US$ 719.83 million in 2022; the Europe noninvasive ventilation masks market is expected to register a CAGR of 5.2% during 2022–2030.

Market Insights and Analyst View:

Noninvasive ventilation (NIV) is the delivery of oxygen (ventilation support) through a face mask, eliminating the need for an endotracheal airway. NIV provides comparable physiological benefits to conventional mechanical ventilation by reducing breathing work and improving gas exchange. The intervention is recognized as an effective treatment for respiratory failure in chronic obstructive pulmonary disease (COPD), cardiogenic pulmonary edema, and other respiratory conditions without complications such as upper airway trauma, ventilator-associated pneumonia, respiratory muscle weakness, and sinusitis. Thus, the increasing prevalence of respiratory diseases significantly impacts the Europe noninvasive ventilation masks market growth.

Growth Drivers and Challenges:

Rising prevalence of chronic obstructive pulmonary diseases (COPD) and respiratory disease in Europe fuels the Europe noninvasive ventilation masks market growth. COPD is one of the most significant public health concerns. According to an article titled “Effectiveness of a home telemonitoring program for patients with chronic obstructive pulmonary disease in Germany” published by the National Library of Medicine in 2022, Germany reported ∼ 6 million COPD cases. According to an article titled “What knows a frail Swiss population about chronic obstructive pulmonary disease?” published in 2021, about 400,000 people were affected by COPD in Switzerland.

Patients with underlying COPDs who suffer from exacerbation of their diseases and hypercapnic dyspnoea or respiratory failure are most likely to be successfully treated with noninvasive ventilation (NIV). NIV effectively relieves the pressure on the respiratory muscles, increases tidal volume, decreases respiratory rate, and reduces the work of diaphragmatic breathing, resulting in an improvement in oxygen supply, a decrease in hypercapnia, and an improvement in dyspnea. A COPD is ideal for NIV as the treatment is quickly reversible, and additional support can be provided.

NIV reduces the endotracheal intubation rate, length of hospital stays, complications of mechanical ventilation, and mortality for COPD patients. Recent clinical practice guidelines recommend NIV as first-line ventilatory support for treating acute respiratory failure (ARF) in COPD. NIV masks are increasingly used to treat people suffering from COPD and respiratory failure.

NIV helps reduce intubation and mortality in patients affected by COPD exacerbation with respiratory failure. The type of mask may impact the success rate. A full-face mask is recommended over nasal masks for patients who are seriously ill and suffer from ARF. Thus, the increasing prevalence of COPD and other respiratory disorders in Europe fuels the Europe noninvasive ventilation masks Europe noninvasive ventilation masks market market growth. Further,

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Europe Noninvasive Ventilation Masks Market: Strategic Insights

europe-noninvasive-ventilation-masks-market
Market Size Value inUS$ 719.83 million in 2022
Market Size Value byUS$ 1,076.68 million by 2030
Growth rateCAGR of 5.2% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Future Trend:

Technological advancements in NIV mask products are expected to bring new Europe noninvasive ventilation masks market trends in the coming years. NIV is the standard care for patients suffering from breathing or sleep-breathing disorders. Technological advancements enable the development of newer modes of automatic NIV adjustment suitable for patients affected by complex breath abnormalities that may be challenging to manage with traditional positive airway pressure therapy effectively. These modes allow stable ventilation when ventilation demands fluctuate. CPAP applies continuous positive airway pressure to non-intubated adult or pediatric patients. It can be used on spontaneously breathing patients who require short-term mechanical assistance. The effectiveness of the treatment is related to the correct sealing of the nasal or full face mask on the patient's face.

The choice of interface is one of the most critical steps for the success of NIV. While developing masks, companies pay great attention to shape, materials, comfort, and leakage reduction. However, the constant evolution of new products increases the availability of interfaces and the ability to meet different requirements. The alternating use of other interfaces can remain an excellent strategy for patients requiring several hours of NIV daily, both in the acute and chronic home environment, to reduce the risk of skin damage and improve patient tolerance. ResMed has offered an intelligent NIV mask that can help tailor treatment to patients' unique and changing needs. Increasing collaborations and R&D investments in the development of technologically advanced products are intended to stimulate the growth of the Europe noninvasive ventilation masks market in the coming years.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Segmental Analysis:

The Europe noninvasive ventilation masks market analysis has been carried out by considering the following segments: interfaces, application, usage, material, size, product type, and end user.

By interfaces, the market is bifurcated into masks and accessories. The masks segment consists of a nasal mask, face mask, nasal pillow mask, oral mask, and total face mask/helmet. Face mask is further sub-segmented into CO2-venting face masks and non-vented face masks. Accessories of NIV masks include elbows and replacement elbows, hoses, tubes, skin barriers, under/over the nose cushions, and head strap/replacement gears. The masks segment consists of nasal mask, face mask, nasal pillow mask, oral mask, and total face mask/helmets. The nasal mask has a triangle structure and is worn around the nose. Four-point headgear that attaches to the frame is typically used to hold the nasal mask in place. The use of nasal mask can irritate the bridge of the nose, where the mask rests. Nasal pillows are cushioning that seal at the base of the nostril and are help in place with a stretchy strap that goes around the back of the head. Nasal pillows fit at the nostrils to supply air pressure.

Full face masks cover the entire face, including the nose and lips. Some have a forehead stabilizer that helps active sleepers get a better cushion seal. The headgear usually has four contact points for stability and easier adjustments. Some manufacturers have lately altered full face masks to sit beneath the user's nose. These designs significantly limit facial contact and reduce the claustrophobia experienced by certain full face mask users.

Total face masks are held in place by four-point headgear and sealed in a broad oval around the complete face to enclose the nose, mouth, and eyes. When receiving treatment for Sleep Apnea, some patients experience a leak of air from the corners of their eyes. Other masks will not operate correctly if this occurs, and a total face mask should be considered. Facial issues can prevent patients from wearing a nasal or full-face mask. A total face mask, like a full-face mask, equalizes the pressure so that the air treatment is consistent, but it also covers the entire face and any areas where air could escape, such as the eyes.

Oral masks use an oval-shaped mask cushion to deliver airflow to the mouth only. These masks are a great alternative to full face masks. It works by creating a seal around the mouth and delivering air through two inlets inside the mask. This method is ideal for those who breathe through their mouth at night

The scope of Europe noninvasive ventilation masks market report includes the assessment of the market performance in the UK, Germany, France, Austria, Switzerland, and the Rest of Europe.

Europe Noninvasive Ventilation Masks Market Share, by Product Type – 2022 and 2030

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Regional Analysis:

Geographically, the Europe noninvasive ventilation masks market is segmented into the UK, Germany, France, Austria, Switzerland, and the Rest of Europe. Germany is the biggest contributor to the market. Noninvasive ventilation is widely used in acute care settings for acute respiratory failure (ARF) across a variety of aetologies. According to an article titled “Effectiveness of a home telemonitoring program for patients with chronic obstructive pulmonary disease in Germany” published by the National Library of Medicine in 2022, Germany records ~6 million COPD cases. NIV effectively relieves the pressure on respiratory muscles, increases the tidal volume, decreases the respiratory rate, and reduces the work of diaphragmatic breathing, resulting in an improvement in oxygen supply, a decrease in hypercapnia, and an improvement in dyspnea. NIV masks is ideal for COPD as the treatment is quickly reversible, and additional support can be provided. Thus, the increase in the prevalence of COPD in Germany fuels the non-invasive ventilation masks market growth in Germany.

Reimbursement policies for medical devices also determine the Europe noninvasive ventilation masks market growth in Germany. NIV masks treatment costs used in intensive care unit (ICU) are reimbursed in the country, and patients have to pay amounts out of their pockets in in-home cases. Favorable reimbursement scenario during hospitalization in Germany drives the growth of the Germany noninvasive ventilation masks market.

Competitive Landscape and Key Companies:

Fisher & Paykel Healthcare Ltd, Armstrong Medical Ltd, Intersurgical Ltd, Hamilton Medical, ResMed, Koninklijke Philips NV, Ambu AS, Dragerwerk AG & Co KGaA, DEAS S.R.L, and SunMed Group Holdings LLC are among the prominent players profiled in the Europe noninvasive ventilation masks market report. In addition, several other players have been studied and analyzed during the study to get a holistic view of the market and its ecosystem. These companies focus on geographic expansions and new product launches to fulfill the growing demand from consumers worldwide and increase their product range in specialty portfolios. Their presence allows them to serve a large customer base, subsequently facilitating the Europe noninvasive ventilation masks market expansion.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Interfaces, Application, Usage, Size, Material, Product Type, End User, and Country

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving and restraining factors for the Europe noninvasive ventilation masks market?

The increasing prevalence of chronic obstructive pulmonary diseases and inclination towards home healthcare propel the market growth. However, the side effects of NIV masks hamper the market's growth. Technological advancement will bring new Europe noninvasive ventilation mask market trends in the coming years.

What is Europe noninvasive ventilation masks?

Non-invasive ventilation (NIV) is the delivery of oxygen (ventilation support) through a face mask, eliminating the need for an endotracheal airway. NIV provides comparable physiological benefits to conventional mechanical ventilation by reducing breathing work and improving gas exchange. The intervention is recognized as an effective treatment for respiratory failure in chronic obstructive pulmonary disease, cardiogenic pulmonary edema, and other respiratory conditions without complications, such as upper airway trauma, ventilator-associated pneumonia, respiratory muscle weakness, and sinusitis.

Which segment is dominating the Europe noninvasive ventilation masks market?

Based on interfaces, the Europe non-invasive ventilation masks market is bifurcated into masks and accessories. The masks segment consists of nasal mask, face mask, nasal pillow mask, oral mask, and total face mask/helmets. Accessories of NIV masks include elbows and replacement elbows, hoses, tubes, skin barriers, under/over the nose cushions, and head strap/replacement gears. In 2022, the masks segment held a larger market share and is expected to record a higher CAGR from 2022 to 2030.

Based on application, the Europe non-invasive ventilation masks market is segmented into respiratory dysfunction, chronic obstructive pulmonary disease, pneumonia, and others. In 2022, the respiratory dysfunction segment held Europe's largest noninvasive ventilation masks market share. Moreover, the same segment is expected to record the highest CAGR during 2022–2030.

Based on usage, the Europe non-invasive ventilation masks market is bifurcated into pediatrics and adults. In 2022, the adult segment held a larger European noninvasive ventilation masks market share. Moreover, the same segment is expected to record a higher CAGR during 2022–2030.

Based on size, the Europe non-invasive ventilation masks market is segmented into large, medium, and small. In 2022, the medium segment held a larger market share and is expected to record a higher CAGR during 2022–2030. Large and medium-size masks are used to treat adults. Growing pollution and smoking is responsible for increasing cases of respiratory diseases and lung-related diseases. Thus, the rising prevalence of respiratory diseases such as COPD, ARF, asthma, and hospital-acquired pneumonia in adults fuels the demand for large and medium-size masks. Furthermore, in patients affected by severe acute asthma, adding NIV to conventional treatment improves lung function and alleviates the exacerbation faster. In patients suffering from COPD, neuromuscular diseases, and obesity hypoventilation syndrome, noninvasive positive pressure ventilation (NIPPV) results in lower mortality, intubations, hospital admissions, and better quality of life. Also, the increase in cases of neurodegenerative diseases and sleep apnea in adults drives the market growth for the segment. Increasing use of masks in treating respiratory diseases fuels the Europe non-invasive ventilation masks market growth for the large and medium segments.

Based on material, the Europe non-invasive ventilation masks market is further segmented into silicon, gel, and others. In 2022, the silicon segment held Europe's largest noninvasive ventilation masks market share. Moreover, the same segment is expected to record the highest CAGR during 2022–2030.

Based on product type, the Europe non-invasive ventilation masks market is bifurcated into single-use and reusable. In 2022, the reusable segment held a larger Europe noninvasive ventilation masks market share. Moreover, the same segment is expected to record a higher CAGR during 2022–2030.

The Europe noninvasive ventilation masks market, by end user, is segmented into hospitals, critical and acute care settings, ambulatory surgical centers, and others. In 2022, the hospital segment held the largest share of the market and is expected to record the highest CAGR from 2022 to 2030.

Who are the major players in market the Europe noninvasive ventilation masks market?

The Europe noninvasive ventilation masks market majorly consists of players such Fisher & Paykel Healthcare Ltd, Armstrong Medical Ltd, Intersurgical Ltd, Hamilton Medical, ResMed, Koninklijke Philips NV, Ambu AS, Dragerwerk AG & Co KGaA, DEAS S.R.L, and SunMed Group Holdings LLC.

1. Introduction

1.1 Scope of the Study

1.2 Market Definition, Assumptions and Limitations

1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights

2.2 Market Attractiveness Analysis

3. Research Methodology

4. Non-Invasive Ventilation Masks Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Non-Invasive Ventilation Masks Market - Key Market Dynamics

5.1 Key Market Drivers

5.2 Key Market Restraints

5.3 Key Market Opportunities

5.4 Future Trends

5.5 Impact Analysis of Drivers and Restraints

6. Non-Invasive Ventilation Masks Market - Europe Market Analysis

6.1 Non-Invasive Ventilation Masks - Europe Market Overview

6.2 Non-Invasive Ventilation Masks - Europe Market and Forecast to 2031

7. Non-Invasive Ventilation Masks Market – Revenue Analysis (USD Million) – By Interfaces, 2020-2030

7.1 Overview

7.2 Masks

7.2.1 Nasal Mask

7.2.2 Face Mask

7.2.2.1 CO2 Venting

7.2.3.1 Non-Vented

7.2.3 Nasal Pillow Mask

7.2.4 Oral Mask

7.2.5 Total face Mask/Helmets

7.3 Accessories

7.3.1 Elbows and replacement elbows

7.3.2 Hoses

7.3.3 Tubes

7.3.4 Skin barriers

7.3.5 Under/over the nose cushions

7.3.6 Head strap/replacement gears

8. Non-Invasive Ventilation Masks Market – Revenue Analysis (USD Million) – By Application, 2020-2030

8.1 Overview

8.2 Respiratory Dysfunction

8.3 Chronic Obstructive Pulmonary Diseases

8.4 Pneumonia

8.5 Others

9. Non-Invasive Ventilation Masks Market – Revenue Analysis (USD Million) – By Usage, 2020-2030

9.1 Overview

9.2 Paediatric

9.3 Adult

10. Non-Invasive Ventilation Masks Market – Revenue Analysis (USD Million) – By Size, 2020-2030

10.1 Overview

10.2 Large

10.3 Medium

10.4 Small

11. Non-Invasive Ventilation Masks Market – Revenue Analysis (USD Million) – By Material, 2020-2030

11.1 Overview

11.2 Silicon

11.3 Gel

11.4 Others

12. Non-Invasive Ventilation Masks Market – Revenue Analysis (USD Million) – By Product Type, 2020-2030

12.1 Overview

12.2 Single Use

12.3 Reusable

13. Non-Invasive Ventilation Masks Market – Revenue Analysis (USD Million) – By End User, 2020-2030

13.1 Overview

13.2 Hospitals

13.3 Critical and Acute Care Settings

13.4 Ambulatory Surgical Centers

13.5 Others

14. Non-Invasive Ventilation Masks Market - Revenue Analysis (USD Million), 2020-2030 – Country Analysis

14.1 Europe

14.1.1 Europe Non-Invasive Ventilation Masks Market Overview

14.1.2 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts to 2031

14.1.3 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts and Analysis - By Interfaces

14.1.4 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts and Analysis - By Application

14.1.5 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts and Analysis - By Usage

14.1.6 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts and Analysis - By Size

14.1.7 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts and Analysis - By Material

14.1.8 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts and Analysis - By Product Type

14.1.9 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts and Analysis - By End User

14.1.10 Europe Non-Invasive Ventilation Masks Market Revenue and Forecasts and Analysis - By Countries

14.1.10.1 Germany Non-Invasive Ventilation Masks Market

14.1.10.1.1 Germany Non-Invasive Ventilation Masks Market, by Interfaces

14.1.10.1.2 Germany Non-Invasive Ventilation Masks Market, by Application

14.1.10.1.3 Germany Non-Invasive Ventilation Masks Market, by Usage

14.1.10.1.4 Germany Non-Invasive Ventilation Masks Market, by Size

14.1.10.1.5 Germany Non-Invasive Ventilation Masks Market, by Material

14.1.10.1.6 Germany Non-Invasive Ventilation Masks Market, by Product Type

14.1.10.1.7 Germany Non-Invasive Ventilation Masks Market, by End User

14.1.10.2 France Non-Invasive Ventilation Masks Market

14.1.10.2.1 France Non-Invasive Ventilation Masks Market, by Interfaces

14.1.10.2.2 France Non-Invasive Ventilation Masks Market, by Application

14.1.10.2.3 France Non-Invasive Ventilation Masks Market, by Usage

14.1.10.2.4 France Non-Invasive Ventilation Masks Market, by Size

14.1.10.2.5 France Non-Invasive Ventilation Masks Market, by Material

14.1.10.2.6 France Non-Invasive Ventilation Masks Market, by Product Type

14.1.10.2.7 France Non-Invasive Ventilation Masks Market, by End User

14.1.10.3 Italy Non-Invasive Ventilation Masks Market

14.1.10.3.1 Italy Non-Invasive Ventilation Masks Market, by Interfaces

14.1.10.3.2 Italy Non-Invasive Ventilation Masks Market, by Application

14.1.10.3.3 Italy Non-Invasive Ventilation Masks Market, by Usage

14.1.10.3.4 Italy Non-Invasive Ventilation Masks Market, by Size

14.1.10.3.5 Italy Non-Invasive Ventilation Masks Market, by Material

14.1.10.3.6 Italy Non-Invasive Ventilation Masks Market, by Product Type

14.1.10.3.7 Italy Non-Invasive Ventilation Masks Market, by End User

14.1.10.4 Spain Non-Invasive Ventilation Masks Market

14.1.10.4.1 Spain Non-Invasive Ventilation Masks Market, by Interfaces

14.1.10.4.2 Spain Non-Invasive Ventilation Masks Market, by Application

14.1.10.4.3 Spain Non-Invasive Ventilation Masks Market, by Usage

14.1.10.4.4 Spain Non-Invasive Ventilation Masks Market, by Size

14.1.10.4.5 Spain Non-Invasive Ventilation Masks Market, by Material

14.1.10.4.6 Spain Non-Invasive Ventilation Masks Market, by Product Type

14.1.10.4.7 Spain Non-Invasive Ventilation Masks Market, by End User

14.1.10.5 United Kingdom Non-Invasive Ventilation Masks Market

14.1.10.5.1 United Kingdom Non-Invasive Ventilation Masks Market, by Interfaces

14.1.10.5.2 United Kingdom Non-Invasive Ventilation Masks Market, by Application

14.1.10.5.3 United Kingdom Non-Invasive Ventilation Masks Market, by Usage

14.1.10.5.4 United Kingdom Non-Invasive Ventilation Masks Market, by Size

14.1.10.5.5 United Kingdom Non-Invasive Ventilation Masks Market, by Material

14.1.10.5.6 United Kingdom Non-Invasive Ventilation Masks Market, by Product Type

14.1.10.5.7 United Kingdom Non-Invasive Ventilation Masks Market, by End User

14.1.10.6 Austria Non-Invasive Ventilation Masks Market

14.1.10.6.1 Austria Non-Invasive Ventilation Masks Market, by Interfaces

14.1.10.6.2 Austria Non-Invasive Ventilation Masks Market, by Application

14.1.10.6.3 Austria Non-Invasive Ventilation Masks Market, by Usage

14.1.10.6.4 Austria Non-Invasive Ventilation Masks Market, by Size

14.1.10.6.5 Austria Non-Invasive Ventilation Masks Market, by Material

14.1.10.6.6 Austria Non-Invasive Ventilation Masks Market, by Product Type

14.1.10.6.7 Austria Non-Invasive Ventilation Masks Market, by End User

14.1.10.7 Switzerland Non-Invasive Ventilation Masks Market

14.1.10.7.1 Switzerland Non-Invasive Ventilation Masks Market, by Interfaces

14.1.10.7.2 Switzerland Non-Invasive Ventilation Masks Market, by Application

14.1.10.7.3 Switzerland Non-Invasive Ventilation Masks Market, by Usage

14.1.10.7.4 Switzerland Non-Invasive Ventilation Masks Market, by Size

14.1.10.7.5 Switzerland Non-Invasive Ventilation Masks Market, by Material

14.1.10.7.6 Switzerland Non-Invasive Ventilation Masks Market, by Product Type

14.1.10.7.7 Switzerland Non-Invasive Ventilation Masks Market, by End User

14.1.10.8 Rest of Europe Non-Invasive Ventilation Masks Market

14.1.10.8.1 Rest of Europe Non-Invasive Ventilation Masks Market, by Interfaces

14.1.10.8.2 Rest of Europe Non-Invasive Ventilation Masks Market, by Application

14.1.10.8.3 Rest of Europe Non-Invasive Ventilation Masks Market, by Usage

14.1.10.8.4 Rest of Europe Non-Invasive Ventilation Masks Market, by Size

14.1.10.8.5 Rest of Europe Non-Invasive Ventilation Masks Market, by Material

14.1.10.8.6 Rest of Europe Non-Invasive Ventilation Masks Market, by Product Type

14.1.10.8.7 Rest of Europe Non-Invasive Ventilation Masks Market, by End User

15. Industry Landscape

15.1 Mergers and Acquisitions

15.2 Agreements, Collaborations, Joint Ventures

15.3 New Product Launches

15.4 Expansions and Other Strategic Developments

16. Competitive Landscape

16.1 Heat Map Analysis by Key Players

16.2 Company Positioning and Concentration

17. Non-Invasive Ventilation Masks Market - Key Company Profiles

17.1 SunMED Medical

17.1.1 Key Facts

17.1.2 Business Description

17.1.3 Products and Services

17.1.4 Financial Overview

17.1.5 SWOT Analysis

17.1.6 Key Developments

Note - Similar information would be provided for below list of companies

17.2 ResMed

17.3 Armstrong Medical Ltd

17.4 Koninklijke Philips N.V.

17.5 Ambu A/S

17.6 Drägerwerk AG and Co. KGaA

17.7 DEAS S.R.L.

17.8 Fisher and Paykel Healthcare Limited

17.9 Intersurgical Ltd

17.10 Hamilton Medical

18. Appendix

18.1 Glossary

18.2 About The Insight Partners

18.3 Market Intelligence Cloud

The List of Companies - Europe Noninvasive Ventilation Masks Market 

  1. Fisher & Paykel Healthcare Ltd
  2. Armstrong Medical Ltd
  3. Intersurgical Ltd
  4. Hamilton Medical
  5. ResMed
  6. Koninklijke Philips NV
  7. Ambu AS
  8. Dragerwerk AG & Co KGaA
  9. DEAS S.R.L
  10. SunMed Group Holdings LLC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Europe Noninvasive Ventilation Masks Market